
Hutchmed Ltd.
Building 4, 720 Cailun Road, China (Shanghai) Pilot Free Trade Zone, 201203
About the sponsor
Research activity includes acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, and lymphoma, with additional interest in angio-immunoblastic T-cell lymphoma and other mIDH-positive hematological malignancies.
- Relapsed and refractory lymphoma
- IDH-mutated blood cancers
- T-cell lymphoma
The sponsor’s portfolio reflects a focus on blood cancers with molecularly defined targets, particularly disease settings where mutational profiling is central to treatment selection.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.
